The manufacture and release of a commercially approved biopharmaceutical drug under cGMP is a complex and expensive operation. The design and construction of a manufacturing plant to handle kilogram quantities of drug substance requires an in-depth understanding of the scale required to support the production, purification, and formulation, as well as the ancillary functions necessary to produce a product that meets the criteria of safety, purity, activity, and batch to batch consistency. This webinar will present a case example of a legacy manufacturing plant designed to deliver a metric ton of monoclonal antibody per annum.
Course Objectives:
• Seeing an example of a large scale manufacturing plant through a pictorial guided tour
• Understanding why the production of biologics is so expensive
• Why microbial control is so important
• In-process testing for a typical biologic
• Release testing for a typical biologic
Why Should You Attend:
An understanding of the complexities and costs associated with the design, manufacturing and release of a biopharmaceutical drug is essential to allow for process development, scale up, launch and commercialization.
Course Outline:
• Overview of development of a drug
• Guided tour through a large scale facility
• Facilities
o Utilities
o Maintenance
• QC/QC activies
o Batch records
o In-Process controls
o Product release testing and CoA
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Process Development scientists
• Facility designers
• Manufacturing Personnel and Managers
• QC/QA
• CMC team leaders
QSR-Compliant Equipment Control & Validation of Processes in the Manufacturing Environment
Get Instant Access 90 Minutes View Program |
Biopharmaceutical Aspects of the Active Pharmaceutical Ingredient and Pharmaceutical Equivalence
Get Instant Access 90 Minutes View Program |
Good Laboratory Practices (GLPS) Comparing and Contrasting With Good Manufacturing Practices (GMPS)
Get Instant Access 90 Minutes View Program |
Bioavailability and Bioequivalence Studies submitted in NDAs and INDs
Get Instant Access 90 Minutes View Program |
Veterinary Feed Directive (VFD) Final Rule – What you need to know?
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry